SRI-35241 is a synthetic peptide inhibitor that targets the activation of transforming growth factor-beta (TGF-β) by thrombospondin 1 (THBS1), effectively acting as both a TGF-β inhibitor and a THBS1 antagonist. Its molecular formula is C₁₁H₂₂N₄O₃, with a molecular weight of 258.32 g/mol. Developed by the Southern Research Institute, SRI-35241 has been investigated in preclinical studies for potential therapeutic applications in fibrosis and neoplasms.
MedKoo Cat#: 593201
Name: SRI-35241
CAS#: 2307429-54-3
Chemical Formula: C11H22N4O3
Exact Mass: 258.1692
Molecular Weight: 258.32
Elemental Analysis: C, 51.15; H, 8.58; N, 21.69; O, 18.58
The following data is based on the product molecular weight 258.32 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
| 5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
| 10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
| 50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
